• 1. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038
• 5. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles

Introduction to 6-bromo-3-chloro-1H-indole (CAS No. 57916-08-2)

6-bromo-3-chloro-1H-indole, identified by its Chemical Abstracts Service (CAS) number 57916-08-2, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the indole family, a class of molecules known for their diverse biological activities and applications in drug development. The presence of both bromine and chlorine substituents on the indole ring enhances its reactivity, making it a valuable intermediate in synthetic chemistry and a promising candidate for further exploration in medicinal chemistry.

The structural features of 6-bromo-3-chloro-1H-indole contribute to its unique chemical properties. The bromine atom at the 6-position and the chlorine atom at the 3-position introduce electrophilic centers, which are susceptible to nucleophilic substitution reactions. This characteristic makes the compound a versatile building block for constructing more complex molecular architectures. In recent years, such halogenated indoles have been extensively studied due to their potential as scaffolds for developing novel therapeutic agents.

One of the most compelling aspects of 6-bromo-3-chloro-1H-indole is its utility in the synthesis of bioactive molecules. Researchers have leveraged its reactive sites to develop a variety of derivatives with enhanced pharmacological properties. For instance, studies have demonstrated that modifications at the bromine and chlorine positions can significantly influence the binding affinity and selectivity of indole-based compounds toward biological targets. This flexibility has enabled the design of molecules with potential applications in oncology, immunology, and neurology.

Recent advancements in computational chemistry and molecular modeling have further highlighted the significance of 6-bromo-3-chloro-1H-indole as a pharmacophore. These tools have been used to predict how structural variations can modulate biological activity, providing insights into rational drug design. By integrating experimental data with computational predictions, scientists are able to optimize lead compounds more efficiently, reducing the time and cost associated with traditional drug discovery processes.

In the realm of medicinal chemistry, 6-bromo-3-chloro-1H-indole has been explored as a precursor for various bioactive scaffolds. For example, researchers have synthesized indole derivatives that exhibit inhibitory effects on enzymes such as kinases and phosphodiesterases. These enzymes are often implicated in disease pathways, making them attractive targets for therapeutic intervention. The halogenated indoles derived from 6-bromo-3-chloro-1H-indole have shown promise in preclinical studies, demonstrating efficacy in models of inflammation and cancer.

The synthesis of 6-bromo-3-chloro-1H-indole itself is an intriguing aspect of organic chemistry. Traditional methods involve halogenation reactions on indole precursors, often employing reagents such as N-bromosuccinimide (NBS) or sulfuryl chloride (SO?Cl?). However, recent innovations have focused on greener and more sustainable synthetic routes. For instance, catalytic halogenation techniques using transition metals have been explored to improve yields and reduce waste. These advancements align with the growing emphasis on environmentally conscious chemical synthesis.

The biological activity of 6-bromo-3-chloro-1H-indole derivatives has been thoroughly investigated in various disease models. One notable area of research is its potential as an antimicrobial agent. Studies have shown that certain halogenated indoles exhibit broad-spectrum activity against Gram-positive and Gram-negative bacteria, as well as fungi. This finding is particularly relevant in light of increasing antimicrobial resistance, where novel therapeutic strategies are urgently needed.

Another promising application lies in neurodegenerative diseases. Indole derivatives have been implicated in modulating neurotransmitter systems, making them candidates for treating conditions such as Alzheimer's disease and Parkinson's disease. The structural diversity offered by 6-bromo-3-chloro-1H-indole allows for the creation of molecules that can interact with specific neural receptors or enzymes involved in these pathologies. Preliminary studies suggest that certain derivatives may enhance cognitive function or mitigate neuroinflammation.

The role of 6-bromo-3-chloro-1H-indole in material science is also emerging as an important area of study. Beyond pharmaceutical applications, halogenated indoles can serve as precursors for organic semiconductors and optoelectronic materials. Their ability to form stable crystal structures and exhibit desirable electronic properties makes them suitable for use in organic light-emitting diodes (OLEDs) and photovoltaic cells. This interdisciplinary approach highlights the broad utility of this compound across multiple scientific domains.

In conclusion, 6-bromo-3-chloro-1H-indole (CAS No. 57916-08-2) represents a fascinating molecule with significant potential in pharmaceuticals, materials science, and beyond. Its unique structural features enable diverse synthetic modifications, leading to a wide array of bioactive derivatives. As research continues to uncover new applications and synthetic strategies, this compound will undoubtedly remain at the forefront of scientific exploration.

• 919522-62-6(1H-Indole, 7-bromo-3,4-dichloro-)
• 180623-89-6(5-Bromo-7-chloro-1H-indole)
• 126811-30-1(4-Bromo-7-chloro-1H-indole)
• 885519-01-7(6-Bromo-4-chloro-1H-indole)
• 1246549-62-1(7-bromo-3-chloro-quinoline)
• 1416438-95-3(6-bromo-3-chloro-quinoline)
• 1215770-74-3(5-bromo-3-chloro-quinoline)
• 75090-52-7(7-Bromo-4-Chloroquinoline)
• 885519-23-3(4-Bromo-6-chloro-1H-indole)
• 927800-40-6(4-Bromo-8-chloroquinoline)